Home ProductsPain Killer Powder

TOP Lidocaine 137-58-6 Local Anaesthetic Drugs Lidocaine Antiarrhythmic Drug

Certification
China Hengyang Desen Biotechnology Co., Ltd. certification
China Hengyang Desen Biotechnology Co., Ltd. certification
Customer Reviews
Awesome, thanks Irina. You've actually been the fastest and most responsive so far, you're going to be getting a lottt of business from me in future.

—— Andressa Hernandez from Brazil

EllenCaisin! I test the product, it is so good! Very happy. and I gave the treats to my family, you might be the best I ever used. best service!!!

—— Gabriel Collin from Canada

Aaron Fantastic! I have received the package. Thank you very much for great packaging. If it is good quality, you must have me as a long time customer

—— Mitch Kelly from USA

Yep Koala! got package thankyou so much, Koala. I like to place another order now. how much is T3 and tren a

—— Joaquin Vega from Spain

I'm Online Chat Now

TOP Lidocaine 137-58-6 Local Anaesthetic Drugs Lidocaine Antiarrhythmic Drug

large.img.alt
small.img.alt small.img.alt small.img.alt small.img.alt

Large Image :  TOP Lidocaine 137-58-6 Local Anaesthetic Drugs Lidocaine Antiarrhythmic Drug

Product Details:
Place of Origin: China
Brand Name: ChineseHormone
Certification: ISO9001,GMP,SGS,UKAS
Model Number: 137-58-6
Payment & Shipping Terms:
Minimum Order Quantity: 10g
Price: Negotiation
Packaging Details: As your demand
Delivery Time: Within 12 hours After Payment
Payment Terms: T/T, Western Union, MoneyGram, BTC
Supply Ability: 100kg per month
Detailed Product Description
Name: Lidocaine CAS: 137-58-6
Assay: 99% Powder: Yes
High Light:

anti inflammatory supplements

,

local anesthetic drugs

 

Lidocaine 137-58-6 pain killer Pharmaceutical Grade Local Anaesthetic Drugs Lidocaine

 

Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

 

Lidocaine

CAS: 137-58-6

Assay: 99%

Appearance: White crystalline powder

Packing: 25kg/drum

EINECS: 205-302-8

Molecular Formula: C14H22N2O

Molecular weight: 234.34

Manufacturer: Lanzport

Usage: Topically used to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.

 

Product Name Lidocaine
Other Name 2-(Diethylamino)-N-(2,6-dimethylphenyl) acetamide
Assay (%) ≥99.5 Odor Characteristic
Color White crystalline powder Cas No. 137-58-6
Molecular Formula C14H22N2O Molecular Weight 234.34
Standard USP30

Function
Main functions are as follows:
1.Local anesthetic.
2. Treating Epilepsy.
3. Treating Asthma.
Applications Main applications are as follows:
Applied in pharmaceuticalfields.
Packing 1kgor 5kg/bag, 25kg/drum
Shelf Life 24 months
Storage Store in sealed containers at cool & dry place. Protect from light, moisture and pest infestation.

 

Product Description:


Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.

Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

 

Product Applications:


The efficacy profile of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Therefore, lidocaine is suitable for infiltration, block, and surface anesthesia. Longer-acting substances such as bupivacaine are sometimes given preference for subdural and epidural anesthesias; lidocaine, though, has the advantage of a rapid onset of action.

Epinephrine vasoconstricts arteries, reducing bleeding and also delays the resorption of lidocaine, almost doubling the duration of anaesthesia. For surface anesthesia, several available formulations can be used e.g. for endoscopies, before intubations, etc. Buffering the pH of lidocaine makes local freezing less painful.[2] Lidocaine drops can be used on the eyes for short ophthalmic procedures.

Relative insensitivity to lidocaine is genetic. In hypokalemic sensory overstimulation, relative insensitivity to lidocaine has been described in people who also have attention deficit hyperactivity disorder.In dental anesthesia, a relative insensitivity to lidocaine can occur for anatomical reasons due to unexpected positions of nerves. Some people with Ehlers-Danlos syndrome are insensitive to lidocaine.

Lidocaine, along with ethanol, ammonia, and acetic acid, has also been proven to be effective in treating jellyfish stings, both numbing the affected area and preventing further nematocyst discharge

Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion.
Lidocaine is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of Lidocaine. Approximately 90% of Lidocaine administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged. The primary metabolite in urine is a conjugate of 4-hydroxy-2, 6-dimethylaniline.

 

More products:

 

Local anesthesia series
Benzocaine (CAS: 94-09-7) 20~30mesh
Benzocaine (CAS: 94-09-7) 200mesh
Benzocaine hydrochloride(CAS:23239-88-5)
Xylocaine(CAS: 137-58-6)
Linocaine hydrochloride(CAS: 6108-05-0)
Procaine (CAS: 59-46-1)
Procaine hydrochloride (CAS: 51-05-8)
Pramoxine hydrochloride (CAS: 637-58-1)
Articaine hydrochloride (CAS: 23964-57-0)
Ropivacaine hydrochloride(CAS:132112-35-7)
Bupivacaine hydrochloride(CAS:14252-80-3)
Levobupivacaine hydrochloride(CAS:27262-48-2)
Propitocaine hydrochloride(CAS:1786-81-8)
Proparacaine hydrochloride(CAS:5875-06-9)
Tetracaine(CAS:94-24-6)
Tetracaine hydrochloride(CAS:136-47-0)
Dibucaine hydrochloride(CAS:61-12-1)

 

TOP Lidocaine 137-58-6  Local Anaesthetic Drugs Lidocaine Antiarrhythmic Drug 0

 

More info:

1. Lead Time: Within 12hours after you payment

2. Delivery Time: 3-7 working days

3. Packing: Very discreet or as your requirement

4. Shipping: DHL / TNT / UPS / HKEMS / FEDEX / ETC.

5. Tracking number: The tracking number will give to you after goods send out at first time.

6. After-sales service: 24/7 online for you to solve problems.

Welcome to order our products.

 

 

 

 

Contact Details
Hengyang Desen Biotechnology Co., Ltd.

Contact Person: Sales Manager

Send your inquiry directly to us (0 / 3000)